We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Antisoma | LSE:ASM | London | Ordinary Share | GB0055696032 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.325 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2011 08:54 | I thought the same duncan - there were no statements above As bookiebuster shows above, the odds are not good for any return above the current market cap. | the_doctor | |
08/2/2011 08:47 | Hardly £23.4m cash Firstly that figure was from 5 weeks ago so add on 5 weeks cash burn Secondly there's nearly £5m in net trade/payables | bookiebuster | |
08/2/2011 08:47 | What are they on about? The statements made above concerning a possible offer for the Company may or may not lead to an offer being made for the entire issued share capital of the Company ('the Possible Offer'). There can be no certainty that an offer will be forthcoming or as to the terms on which such an offer might be made. The Company, which is being advised by Canaccord Genuity Limited, will make a further announcement when appropriate | duncandisorderly | |
08/2/2011 08:43 | Why? £23.4 million in cash, downsizing and is that an offer being made for the company? The statements made above concerning a possible offer for the Company may or may not lead to an offer being made for the entire issued share capital of the Company ('the Possible Offer'). There can be no certainty that an offer will be forthcoming or as to the terms on which such an offer might be made. The Company, which is being advised by Canaccord Genuity Limited, will make a further announcement when appropriate. Number of Relevant Securities in Issue: In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the 'Code'), the Company's issued share capital consists of 632,462,777 ordinary shares with a nominal value of 1 pence each ('Ordinary Shares'), each share having equal voting rights. The ISIN number of the Ordinary Shares is GB0055696032 Canaccord Genuity Limited Tel: +44 (0)20 7050 6500 Robert Finlay Henry Fitzgerald-O'Connor Kit Stephenson Canaccord Genuity Limited ("Canaccord Genuity"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Antisoma and no one else in connection with the Possible Offer and will not be responsible for anyone other than Antisoma for providing the protections afforded to clients of Canaccord Genuity or for providing advice in relation to the Possible Offer, or any matter referred to herein. Disclosure requirements of the Takeover Code (the 'Code') | pwhite73 | |
08/2/2011 08:04 | Looks doomed IMHO | clubman | |
08/2/2011 08:00 | Am I missing something?I t comes out with all the rns rubbish that we know then half way down it refers to how a,"possible offer for the company"cannot be guaranteed and all that twaddle.Have they received an approach because I can't see it in the rns? | duncandisorderly | |
08/2/2011 07:09 | Looks to have found some buyers, still very risky could go bust. | clubman | |
07/2/2011 16:51 | Funny old world, price up at the close with a 10,000,000 sell at 4.35pm. | freddie ferret | |
07/2/2011 07:23 | re.AML look at sar today, they've cracked it,... | dahmmy | |
04/2/2011 09:01 | Wow a 10 million share deal at 8.57am Is this ORA again? and another 5 million one at 9.02 am | ajmace | |
04/2/2011 00:54 | ORA, the investment vehicle of Richard Griffiths, founder of the investment bank Evolution, declared a 10.8 per cent stake in Antisoma, the drug developer that has developed a string of drugs that do not work. With the Welsh Wizard's reputation for unlocking shareholder value, it would be no surprise if he pushed for Antisoma to be wound up to release its remaining £23.4 million of cash. Shares that changed hands for 214½p in 2001 edged another 3 per cent lower to 2¼p. They were never cheaper. | pwhite73 | |
03/2/2011 23:47 | Good point. But the one thing that separates Antisoma from all the others mentioned is that it actually has the money to apply for licences, explore and mine for gold. At 2.3p, ORA owning 11% and £23 million in the bank the real journey for ASM shareholders is just about to beginning. | pwhite73 | |
03/2/2011 22:12 | bigwadds - 3 Feb'11 - 20:44 - 5514 of 5514 "Ultimately though, the company has no real drug remedy which could be introduced and marketed before they run out of funds." Absolutely. This is why I think there will be an announcement shortly regarding a complete change of the company's business. The £23 million cash pile will be put to use in a business that is less risky and offers more immediate returns, like gold mining. | pwhite73 | |
03/2/2011 10:13 | People still buying. Am I missing something. As the great WB said go against the herd. Did he mean sheep. | clubman | |
03/2/2011 08:47 | PWhite73 I agree with your rationale. Please note: I believe the share movements were happening for months around the 6p mark. Me and Freddie Ferret made several observations and stated them on ther board. I agree that someone is aquiring and to be doing that must have had prior knowledge to the last RNS content.(Crystal balls). They will be in control of the share price and much to my disgust i expect the price to oscillate around this area for the interim whilst they take shares from weak holders. The only thing on your side is the time pressure of cash burn. So whatever they are up to they will have to do sooner than later. This is a double your money against lose most of it punt. If you held ASM you may have emotional attachment. If your new to it then your evaluation will at least be made on current fundamentals. Expect the unexpected. The next results may not be what you expect. Best of luck and good hunting. Regards. W. | wilba | |
03/2/2011 08:33 | Wilba ACE like all delisted companies simply ran out of money. See RNS 01 September 2010. It is not as easy to delist as people seem to think. A case has to be put to the LSE and the FSA. ASM cannot delist when it announce on 31 January 2011 it has £23.4 million in the bank. | pwhite73 | |
03/2/2011 08:26 | Agreed pwhite.Stock in ASM is getting picked up deliberately and methodically.This will end up at least 4p. | duncandisorderly | |
03/2/2011 08:26 | I suggest you have a look at ACE and its recent delisting. Thank you for the gramma lesun. I wish you well. Three sequential failures is a disaster and has come at a very bad time for the BIO sector in general. | wilba | |
03/2/2011 08:13 | So ORA (Guernsey) Limited are picking up the shares the others are selling. I would imagine ORA made them an offer for their stock. If you look at their website it does appear to me they have plans to invest or merge one or more of their AIM businesses with Antisoma. | pwhite73 | |
03/2/2011 08:13 | Interesting......... Welcome to ORA Capital Partners Limited The principal activity of ORA is the growth and development of businesses in which ORA has or acquires either a significant minority or a majority shareholding. ORA's holding generally results from participation in the formation of new businesses or from acquisitions. | duncandisorderly | |
02/2/2011 20:46 | Henderson Morley (HML) | bookiebuster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions